Literature DB >> 8410541

Cryopreservation of infective larvae of Onchocerca volvulus (Filarioidea: Onchocercidae).

M Trpis1, G A Scoles, R H Struble.   

Abstract

Infective larvae (L3) of Onchocerca volvulus were procured in Liberia, West Africa, in the natural black fly vector, Simulium yahense. A cryobiological technique was developed to preserve L3 of O. volvulus that were fully viable after thawing. Larvae were treated before cooling with 4 cryoprotective compounds. Three compounds, dimethyl sulfoxide (DMSO), glycerol, and ethylene glycol, were prepared with distilled water. The fourth compound was DMSO prepared in different concentrations with 0.25 M sucrose. The treatment with DMSO + 0.25 M sucrose cryoprotectant resulted in the highest survival of infective larvae. Five cooling rates between 0.5 C/min and 20.0 C/min were applied. The highest survival of L3 was with the cooling rate of 1.0 C/min. Two-step cooling of L3 was applied. In the first step, L3's were frozen to 5 levels from -10.0 C to -20.0 C, -30.0 C, -40.0 C, -60 C, and -80.0 C, and in the second step, larvae were transferred into liquid nitrogen at -196 C for rapid cooling and storage. The survival was the highest when larvae were cooled to approximately -40 C prior to transfer into liquid nitrogen. Slow, gradual, and rapid thawing procedures were applied. The survival was the highest in rapid warming.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8410541

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  6 in total

1.  Protective immunity to the larval stages of onchocerca volvulus is dependent on Toll-like receptor 4.

Authors:  Laura A Kerepesi; Ofra Leon; Sarah Lustigman; David Abraham
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model.

Authors:  Jessica A Hess; Bin Zhan; Sandra Bonne-Année; Jessica M Deckman; Maria Elena Bottazzi; Peter J Hotez; Thomas R Klei; Sara Lustigman; David Abraham
Journal:  Int J Parasitol       Date:  2014-06-05       Impact factor: 3.981

3.  Development of Onchocerca volvulus in humanized NSG mice and detection of parasite biomarkers in urine and serum.

Authors:  John B Patton; Sasisekhar Bennuru; Mark L Eberhard; Jessica A Hess; April Torigian; Sara Lustigman; Thomas B Nutman; David Abraham
Journal:  PLoS Negl Trop Dis       Date:  2018-12-12

4.  Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice.

Authors:  Nathan M Ryan; Jessica A Hess; Fernando Pardo-Manuel de Villena; Benjamin E Leiby; Ayako Shimada; Lei Yu; Amir Yarmahmoodi; Nikolai Petrovsky; Bin Zhan; Maria Elena Bottazzi; Benjamin L Makepeace; Sara Lustigman; David Abraham
Journal:  NPJ Vaccines       Date:  2021-01-26       Impact factor: 7.344

Review 5.  Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi.

Authors:  Bin Zhan; Maria Elena Bottazzi; Peter J Hotez; Sara Lustigman
Journal:  Front Cell Infect Microbiol       Date:  2022-04-04       Impact factor: 6.073

6.  The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice.

Authors:  Jessica A Hess; Bin Zhan; April R Torigian; John B Patton; Nikolai Petrovsky; Tingting Zhan; Maria Elena Bottazzi; Peter J Hotez; Thomas R Klei; Sara Lustigman; David Abraham
Journal:  PLoS Negl Trop Dis       Date:  2016-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.